View Post

Rare Patient Voice: Research opportunity for Cervical Cancer patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Details: 60 min web-assisted phone interview Please sign up at the link below to receive an email invite to the survey.  Compensation $125 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to …

View Post

Ancora.ai: New Jersey-Based Patients with cervical, ovarian, or uterine cancer

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Eligibility Criteria People living in New Jersey who have had treatment for cervical, ovarian, or uterine cancer in the past 2 years. Study Details 1-hour virtual interview conducted via computer Compensation $150 Link to Sign up https://www.surveymonkey.de/r/NJ_Women Why sign up with Ancora.ai?    Participating in research is an incredible way to share your personal opinions and insights to help improve cancer …

View Post

Rare Patient Voice: Paid Opportunity for Cervical Cancer Patients and Caregivers

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Details: 60 min phone interview Compensation $100 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! Why Sign …

View Post

Rare Patient Voice: Study Opportunity for Cervical Cancer Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 60 min Web-Assisted Phone Interview Compensation $125 Please sign up at the link below for more information or to see if you qualify. https://rarepatientvoice.com/LetLifeHappen/ Why Sign up with Rare Patient Voice? Who knows better than you about your journey and experiences?  We connect you with researchers who are developing products and services which can help you and others …

View Post

Federal Programs Provide Screening and Treatment for Breast and Cervical Cancer

In In The News by Barbara Jacoby

From: gao.gov Tens of thousands of people die each year from breast or cervical cancer. Early screening, detection, and prompt treatment saves lives. The Centers for Disease Control and Prevention’s Early Detection Program provides screening and diagnostic services to low-income and uninsured or underinsured people. States may extend Medicaid to people who aren’t otherwise eligible if they are screened under …

View Post

Seattle Genetics Announces Positive Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer

In Clinical Studies News by Barbara Jacoby

From: businesswire.com Seattle Genetics, Inc. (Nasdaq:SGEN) today announced positive topline results from the phase 2 single-arm clinical trial known as innovaTV 204 evaluating tisotumab vedotin administered every three weeks for the treatment of patients who have relapsed or progressed on or after prior treatment for recurrent or metastatic cervical cancer. Results from the trial showed a 24 percent confirmed objective …

View Post

It’s Time to Get Back to Your Regular Screenings

In In The News by Barbara Jacoby

By: Tampa Bay Radiation Oncology Your risk of developing cancer can be reduced by choosing healthy lifestyle habits, including a healthy diet, exercise, not smoking—and maintaining regular screenings. Screenings are designed to look for cancer before you have any signs or symptoms, because, by the time cancer symptoms appear, your cancer may have already progressed and spread. Regular screenings may …

View Post

ASTRO issues first clinical guideline on radiation therapy for cervical cancer

In In The News by Barbara Jacoby

Recommendations address external beam radiation, chemoradiation and brachytherapy for postoperative and definitive management of nonmetastatic disease A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations for radiation therapy to treat patients with nonmetastatic cervical cancer. The guideline—ASTRO’s first for cervical cancer—outlines indications and best practices for external beam radiation therapy and brachytherapy in the postoperative …

View Post

Baylor recruiting participants for cervical cancer clinical trial

In Clinical Studies News by Barbara Jacoby

From: Molly Chiu From: bcm.edu Researchers at Baylor College of Medicine are recruiting volunteers for a clinical trial to test an oral targeted therapy for patients with metastatic cervical cancer. They are looking for women age 18 and older with stage IV cervical cancer who have completed three to six treatments of carbo/taxol with clinical evidence of complete or partial …

View Post

FDA Approvals in Non-Hodgkin Lymphoma, Breast Cancer, GVHD, and Mesothelioma

In In The News by Barbara Jacoby

By: Kristi Rosa From: onclive.com FDA approvals in non-Hodgkin lymphoma, breast cancer, graft-versus-host disease, and mesothelioma, and a breakthrough therapy designation in cervical cancer. The FDA has approved the R2 regimen of lenalidomide plus rituximab for use in patients with previously treated follicular lymphoma and marginal zone lymphoma. The approval was primarily based on findings from the phase III AUGMENT …